Tracer has developed a proprietary platform for tumor-informed circulating-tumor DNA detection using digital PCR.

Labcorp will acquire portions of the lab's clinical and women's health testing businesses, while MAWD will continue to provide anatomic and other pathology services.

Last week, readers were most interested in a story about Gates Foundation Awards to Detact Diagnostics to further develop a POC system and assays to detect infectious diseases.

The new Cobas 6800/8800 systems 2.0 enhances throughput and run flexibility and enables sample prioritization.

The company has requested a hearing and paid a $20,000 fee to delay its delisting determination until Jan. 9, 2025.

NEW YORK – The US Attorney's Office for the District of New Jersey said Thursday that the owner of a New York-based consulting firm has pleaded guilty to charges related to a $5.3 million COVID-19 ...

The firm also has plans for tests beyond sepsis, including for cardiac events and other conditions that are commonly treated in acute care settings.

NEW YORK – Bio-Techne announced on Thursday that it has inked a distribution deal with MedSanTek to distribute Bio-Techne products in Turkey.

NEW YORK – Altona Diagnostics said on Thursday that it has received the European Union's In Vitro Diagnostic Regulation certification for the company's PCR-based tests, and the company plans to launch ...

The deal involves the implementation in Limbach Group labs of Noul's automated MiLab instrument that uses microscopy and AI-developed algorithms to analyze samples.

The PD-L1 IHC 28-8 PharmDx test is used to provide information on PD-L1 expression as a biomarker for patient response to therapies containing anti-PD-1 antibodies.